24 results
Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction - FLOWER-MI
26 May 2021
This investigator-initiated randomised, open-label, multicentre trial compares FFR versus angiography guided strategies for treating non-culprit lesions in patients presenting with STEMI and multivessel coronary artery disease. The results of this study were released during ACC.21.
Reviewer
Reviewer
Novel Supreme DES with early synchronized antiproliferative drug delivery to inhibit smooth muscle cell proliferation after DES implantation in coronary artery disease: results of the PIONEER III randomized clinical trial
06 May 2021
The PIONEER III trial aims to assess the effectiveness and safety of the biodegradable-polymer sirolimus-eluting Supreme stent compared to durable-polymer everolimus-eluting stent (Xience or Promus), completely releasing the drug by 120 days.
Reviewer
Impact of post-stenting fractional flow reserve on long-term clinical outcomes - The FFR-SEARCH Study
29 Apr 2021
The objective of this analysis was to prospectively investigate the clinical impact of post-PCI FFR values on long-term clinical outcomes.
Reviewer
Long-term safety of drug-coated devices for peripheral revascularisation
01 Feb 2021
In this large cohort, there was no evidence of increased long-term mortality following treatment with drug-coated devices. Read the review to find out more.
Reviewer
- ← previous
- 1
- 2
- 3
- next →